← All diseases
Cancer
Glioblastoma
Would you like to receive a message when there is new research about Glioblastoma? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication you'll find one sentence explaining what was studied — and you'll be notified as soon as there is new research on Glioblastoma. View what Premium costs.
Publications and studies (2295)
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Toward more accurate preclinical glioblastoma modeling: Reverse translation of clinical standard of care in a glioblastoma mouse model. (2024/01/01) ♡
- Methods behind oncolytic virus-based DC vaccines in cancer: Toward a multiphase combined treatment strategy for Glioblastoma (GBM) patients. (2024/01/01) ♡
- Clinical diagnosis and management of multiple cerebral ring-enhancing lesions-study of 50 patients at a tertiary healthcare center. (2024/01/01) ♡
- Cooperatively inhibition effect of miR-143-5p and miR-145-5p in tumorigenesis of glioblastoma cells through modulating AKT signaling pathway. (2024/01/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Synergism of d-limonene and temozolomide on migratory and apoptotic behaviors of human glioblastoma cell lines. (2024/01/01) ♡
- SENP1-Mediated deSUMOylation Regulates the Tumor Remodeling of Glioma Stem Cells Under Hypoxic Stress. (2024/01/01) ♡
- The global immune-nutrition-inflammation index (GINI) as a robust prognostic factor in glioblastoma patients treated with the standard Stupp protocol. (2024/01/01) ♡
- Regulatory Mechanisms of STAT3 in GBM and its Impact on TMZ Resistance. (2024/01/01) ♡
- Investigative needle core biopsies for multi-omics in Glioblastoma. (2023/12/31) ♡
- Image-Based Assessment of Natural Killer Cell Activity against Glioblastoma Stem Cells. (2023/12/29) ♡
- Correction: Chen et al. Targeted Extracellular Vesicles Delivered Verrucarin A to Treat Glioblastoma. Biomedicines 2022, 10, 130. (2023/12/29) ♡
- Light-activatable and hyperthermia-sensitive "all-in-one" theranostics: NIR-II fluorescence imaging and chemo-photothermal therapy of subcutaneous glioblastoma by temperature-sensitive liposome-containing AIEgens and paclitaxel. (2023/12/28) ♡
- Enrichment of a neutrophil-like monocyte transcriptional state in glioblastoma myeloid suppressor cells. (2023/12/28) ♡
- Generation of Viral Particles with Brain Cell-Specific Tropism by Pseudotyping HIV-1 with the Zika Virus E Protein. (2023/12/28) ♡
- De Ritis ratio in elderly glioblastoma patients treated with chemoradiation: A comprehensive analysis of serum biomarkers. (2023/12/28) ♡
- Toward image-based personalization of glioblastoma therapy: A clinical and biological validation study of a novel, deep learning-driven tumor growth model. (2023/12/27) ♡
- Pembrolizumab alters the tumor immune landscape in a patient with dMMR glioblastoma. (2023/12/26) ♡
- Wnt inhibition alleviates resistance to immune checkpoint blockade in glioblastoma. (2023/12/26) ♡
- Postoperative Magnetic Resonance Imaging (MRI) Scans for the Surgical Resection of Cranial Glial Tumors According to National Institute of Health and Care Excellence (NICE) Guidelines: A Single-Center Experience. (2023/12/24) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Exploring the multifaceted role of NRF2 in brain physiology and cancer: A comprehensive review. (2023/12/23) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Novel Therapies in Glioblastoma Treatment: Review of Glioblastoma; Current Treatment Options; and Novel Oncolytic Viral Therapies. (2023/12/23) ♡
- Photothermal Prussian blue nanoparticles generate potent multi-targeted tumor-specific T cells as an adoptive cell therapy. (2023/12/22) ♡
- Chinese herb related molecules Catechins, Caudatin and Cucurbitacin-I inhibit the proliferation of glioblastoma by activating KDELR2-mediated endoplasmic reticulum stress. (2023/12/20) ♡
- RNF213 inhibits migration in lung adenocarcinoma cell. (2023/12/20) ♡
- MGMT function determines the differential response of ATR inhibitors with DNA-damaging agents in glioma stem cells for GBM therapy. (2023/12/19) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Toxicity Evaluation and Controlled-Release of Curcumin-Loaded Amphiphilic Poly-N-vinylpyrrolidone Nanoparticles: In Vitro and In Vivo Models. (2023/12/19) ♡
- TGF-β and BMP signaling are associated with the transformation of glioblastoma to gliosarcoma and then osteosarcoma. (2023/12/19) ♡
- Differential Expression of SRY-Related HMG-Box Transcription Factor 2, Oligodendrocyte Lineage Transcription Factor 2, and Zinc Finger E-Box Binding Homeobox 1 in Serum-Derived Extracellular Vesicles: Implications for Mithramycin Sensitivity and Targeted Therapy in High-Grade Glioma. (2023/12/18) ♡
- Gene signatures associated with prognosis and chemotherapy resistance in glioblastoma treated with temozolomide. (2023/12/18) ♡
- StemnesScoRe: an R package to estimate the stemness of glioma cancer cells at single-cell resolution. (2023/12/15) ♡
- Choreographed expansion of services results in decreased patient burden without compromise of outcomes: An assessment of the Ontario experience. (2023/12/14) ♡
- Effects of Levetiracetam and Lacosamide on survival and seizure control in IDH-wild type glioblastoma during temozolomide plus radiation adjuvant therapy. (2023/12/14) ♡
- Evaluating synthetic neuroimaging data augmentation for automatic brain tumour segmentation with a deep fully-convolutional network. (2023/12/14) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Diagnosing pseudoprogression in glioblastoma: A challenging clinical issue. (2023/12/13) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Role of N6-methyladenosine methylation in glioma: recent insights and future directions. (2023/12/11) ♡
- Insulin feedback is a targetable resistance mechanism of PI3K inhibition in glioblastoma. (2023/12/08) ♡
- miRNA-194-3p represses NF-κB in gliomas to attenuate iPSC genes and proneural to mesenchymal transition. (2023/12/07) ♡
- Comprehensive analysis and immunohistochemistry localization of NRP1 expression in pancancer and normal individual tissues in relation to SARS‑CoV‑2 susceptibility. (2023/12/05) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Intraoperative glioblastoma surgery-current challenges and clinical trials: An update. (2023/12/02) ♡
- Phase 1, Dose Escalation, Nonrandomized, Open-Label, Clinical Trial Evaluating the Safety and Preliminary Efficacy of Allogenic Adipose-Derived Mesenchymal Stem Cells for Recurrent Glioblastoma: A Clinical Trial Protocol. (2023/12/01) ♡
- Homeostatic iron regulatory protein drives glioblastoma growth via tumor cell-intrinsic and sex-specific responses. (2023/11/28) ♡
- Response to van Zandvoort et al. "Using a single neuropsychological task as a red flag creates false security". (2023/11/25) ♡
- Corrigendum to "A novel FGFR1 inhibitor CYY292 suppresses tumor progression, invasion, and metastasis of glioblastoma by inhibiting the Akt/GSK3β/snail signaling axis" [Genes & Diseases 11 (2024) 479-494]. (2023/11/15) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Treatment with tumor-treating fields (TTFields) suppresses intercellular tunneling nanotube formation in vitro and upregulates immuno-oncologic biomarkers in vivo in malignant mesothelioma. (2023/11/13) ♡
- Unsupervised machine learning models reveal predictive clinical markers of glioblastoma patient survival using white blood cell counts prior to initiating chemoradiation. (2023/11/11) ♡
- Cytotoxic and apoptotic efficacy of Alkanna tinctoria on glioma cells. (2023/11/01) ♡
- Chemical composition and anticancer activity of the essential oil from Vicia ochroleuca Ten., quite rare plant in Kabylia (Algeria). (2023/11/01) ♡
- A retrospective chart review to identify the involvement of palliative care with glioblastoma multiforme patients. (2023/11/01) ♡
- Supplementation with a high-glucose drink stimulates anti-tumor immune responses to glioblastoma via gut microbiota modulation. (2023/10/31) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. BTLA and HVEM: Emerging players in the tumor microenvironment and cancer progression. (2023/10/28) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.